TrialCritical care (London, England)2021

Ceftolozane/tazobactam probability of target attainment and outcomes in participants with augmented renal clearance from the randomized phase 3 ASPECT-NP trial.

Andrew F Shorr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.